RHY 4.92% 5.8¢ rhythm biosciences limited

Ann: Appendix 4C, page-2

  1. 194 Posts.
    lightbulb Created with Sketch. 37
    Nothing not to like here. A good update. Costs in check and plenty of cash in the bank. Development milestones hit on time and on budget. They did mention in a previous update about recruiting patients for trial 7 in Q1 ‘19. It seems they need to upscale and finalise kit development and commence trial 6 (concurrently?) before that will happen so it’s likely a ways down the track. Rhy is the long game and I’m sure there’s a lot going on behind the scenes and Rhythm are building relationships with partners, government and the healthcare community to make Colostat a reality. Hopefully regular updates to follow...
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
5.8¢
Change
-0.003(4.92%)
Mkt cap ! $14.41M
Open High Low Value Volume
6.1¢ 6.1¢ 5.8¢ $9.662K 161.7K

Buyers (Bids)

No. Vol. Price($)
4 267838 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
5.9¢ 175 1
View Market Depth
Last trade - 15.57pm 19/07/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.